These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22192536)

  • 1. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
    Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
    Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
    Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D
    Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.
    Dou S; Yao YD; Yang XZ; Sun TM; Mao CQ; Song EW; Wang J
    J Control Release; 2012 Aug; 161(3):875-83. PubMed ID: 22762887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.
    Huang H; Yu H; Tang G; Wang Q; Li J
    Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
    Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
    Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.
    Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS
    Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
    Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
    J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine.
    Chiu SJ; Ueno NT; Lee RJ
    J Control Release; 2004 Jun; 97(2):357-69. PubMed ID: 15196762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins.
    Medina-Kauwe LK; Maguire M; Kasahara N; Kedes L
    Gene Ther; 2001 Dec; 8(23):1753-61. PubMed ID: 11803394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
    Li X; Stuckert P; Bosch I; Marks JD; Marasco WA
    Cancer Gene Ther; 2001 Aug; 8(8):555-65. PubMed ID: 11571533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
    Shishido T; Mieda H; Hwang SY; Nishimura Y; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5726-31. PubMed ID: 20801029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
    Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
    Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
    Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
    J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticles.
    Narsireddy A; Vijayashree K; Irudayaraj J; Manorama SV; Rao NM
    Int J Pharm; 2014 Aug; 471(1-2):421-9. PubMed ID: 24939618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
    Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
    Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.